HUP9802096A2 - Piperidino-alkanol-vegyületeket tartalmazó orális adagolású oldat formájú gyógyszerkészítmény, és eljárás előállítására - Google Patents

Piperidino-alkanol-vegyületeket tartalmazó orális adagolású oldat formájú gyógyszerkészítmény, és eljárás előállítására

Info

Publication number
HUP9802096A2
HUP9802096A2 HU9802096A HUP9802096A HUP9802096A2 HU P9802096 A2 HUP9802096 A2 HU P9802096A2 HU 9802096 A HU9802096 A HU 9802096A HU P9802096 A HUP9802096 A HU P9802096A HU P9802096 A2 HUP9802096 A2 HU P9802096A2
Authority
HU
Hungary
Prior art keywords
producing
pharmaceutical composition
oral pharmaceutical
solution form
approximately
Prior art date
Application number
HU9802096A
Other languages
English (en)
Inventor
Gail H. Hurst
Thomas T. Ortyl
Paul F. Skultety
Original Assignee
Hoechst Marion Roussel, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel, Inc. filed Critical Hoechst Marion Roussel, Inc.
Publication of HUP9802096A2 publication Critical patent/HUP9802096A2/hu
Publication of HUP9802096A3 publication Critical patent/HUP9802096A3/hu
Publication of HU227710B1 publication Critical patent/HU227710B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány tárgya őrális adagőlásra alkalmas, őldat főrmájúgyógyszerkészítmény, mely a) a (IIIa) általánős képletű piperidinő-alkanől-vegyület vagy egyesőptikai izőmerjei terápiásan hatásős mennyiségét tartalmazza, ahől azáltalánős képletben X jelentése körülbelül 0-5 közötti egész szám, és b) őlyan alkalmas őldószerrendszert is tartalmaz, amelyőldószerrendszer körülbelül 98,5 tömeg% prőpilén-glikől, illetvekörülbelül 1,5 tömeg% jégecetsav-tartalmú az őldószerrendszer teljestömegére vőnatkőztatva. A találmány szerinti készítmény gyógyszerészetben alkalmazzák. ŕ
HU9802096A 1995-06-06 1996-04-30 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form and process for producing it HU227710B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/469,392 US5574045A (en) 1995-06-06 1995-06-06 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
PCT/US1996/005968 WO1996039139A1 (en) 1995-06-06 1996-04-30 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form

Publications (3)

Publication Number Publication Date
HUP9802096A2 true HUP9802096A2 (hu) 1999-01-28
HUP9802096A3 HUP9802096A3 (en) 1999-06-28
HU227710B1 HU227710B1 (en) 2011-12-28

Family

ID=23863607

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802096A HU227710B1 (en) 1995-06-06 1996-04-30 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form and process for producing it

Country Status (22)

Country Link
US (1) US5574045A (hu)
EP (1) EP0831820B1 (hu)
JP (1) JP4091655B2 (hu)
KR (1) KR100509316B1 (hu)
CN (1) CN1139386C (hu)
AR (1) AR002191A1 (hu)
AT (1) ATE256465T1 (hu)
AU (1) AU707218B2 (hu)
CA (1) CA2218643C (hu)
DE (1) DE69631132T2 (hu)
DK (1) DK0831820T3 (hu)
ES (1) ES2211954T3 (hu)
HU (1) HU227710B1 (hu)
IL (1) IL118525A (hu)
MX (1) MX9709453A (hu)
NO (1) NO318029B1 (hu)
NZ (1) NZ307370A (hu)
PT (1) PT831820E (hu)
SI (1) SI0831820T1 (hu)
TW (1) TW460283B (hu)
WO (1) WO1996039139A1 (hu)
ZA (1) ZA964517B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
CA2449419C (en) * 1994-05-18 2011-09-06 Aventis Pharmaceuticals Inc. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
MX9706449A (es) * 1995-02-28 1997-11-29 Hoechst Marion Roussel Inc Composicion farmaceutica para compuestos de piperidinalcanol.
ES2107375B1 (es) * 1995-08-01 1998-07-01 Almirall Prodesfarma Sa Formulaciones farmaceuticas liquidas de ebastina por via oral.
US6451815B1 (en) 1997-08-14 2002-09-17 Aventis Pharmaceuticals Inc. Method of enhancing bioavailability of fexofenadine and its derivatives
BR9812001A (pt) * 1997-08-26 2000-09-26 Hoechst Marion Roussel Inc Composição farmacêutica para combinação de descongestionante piperidinoalcanol
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
US6613906B1 (en) * 2000-06-06 2003-09-02 Geneva Pharmaceuticals, Inc. Crystal modification
US20060205752A1 (en) * 2005-03-14 2006-09-14 Keith Whitehead Stabilized hydrocodone pharmaceutical compositions with ethylenediaminetetraacetic acid

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US3806526A (en) * 1972-01-28 1974-04-23 Richardson Merrell Inc 1-aroylalkyl-4-diphenylmethyl piperidines
US3966949A (en) * 1973-10-12 1976-06-29 Richardson-Merrell Inc. Pharmaceutical compositions and preparing same
US4285957A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4285958A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
EP0111114A3 (de) * 1982-11-06 1985-10-09 Telefonbau und Normalzeit GmbH Schaltungsanordnung für eine Fernsprechvermittlungsanlage, insbesondere Fernsprechnebenstellenanlage mit zusätzlichem Datenverkehr
DK164642C (da) * 1984-08-30 1992-12-14 Merrell Dow Pharma Farmaceutisk middel indeholdende terfenadin i form af en varmsmelte paafyldt paa kapsler
US4929605A (en) * 1987-10-07 1990-05-29 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol derivatives
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
ZA90341B (en) * 1989-01-23 1990-10-31 Merrell Dow Pharma Liquid pharmaceutical composition for piperidinoalkanol derivatives
US4966061A (en) * 1989-03-27 1990-10-30 Riera John F Tube cutting apparatus

Also Published As

Publication number Publication date
MX9709453A (es) 1998-02-28
HU227710B1 (en) 2011-12-28
DE69631132T2 (de) 2004-08-19
KR19990022504A (ko) 1999-03-25
TW460283B (en) 2001-10-21
JP4091655B2 (ja) 2008-05-28
DE69631132D1 (de) 2004-01-29
NZ307370A (en) 1999-07-29
WO1996039139A1 (en) 1996-12-12
CN1139386C (zh) 2004-02-25
JPH11506115A (ja) 1999-06-02
AU707218B2 (en) 1999-07-08
NO975680L (no) 1998-02-05
AR002191A1 (es) 1998-01-07
CN1187125A (zh) 1998-07-08
EP0831820B1 (en) 2003-12-17
PT831820E (pt) 2004-05-31
DK0831820T3 (da) 2004-04-13
EP0831820A1 (en) 1998-04-01
ATE256465T1 (de) 2004-01-15
IL118525A (en) 2001-07-24
SI0831820T1 (en) 2004-04-30
ZA964517B (en) 1996-12-09
HUP9802096A3 (en) 1999-06-28
NO318029B1 (no) 2005-01-24
CA2218643C (en) 2001-12-11
NO975680D0 (no) 1997-12-05
ES2211954T3 (es) 2004-07-16
IL118525A0 (en) 1996-10-16
AU5669596A (en) 1996-12-24
US5574045A (en) 1996-11-12
KR100509316B1 (ko) 2005-11-25
CA2218643A1 (en) 1996-12-12

Similar Documents

Publication Publication Date Title
ATE103267T1 (de) 7-substituierte derivate der 3,5-dihydroxyhept-6- insaeure, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, sowie zwischenprodukte.
ATE202337T1 (de) Cyclopropylalkansäurederivate
KR960034178A (ko) 벤자제핀- 벤즈옥사제핀- 및 벤조티아제핀-n- 아세트산 유도체와 그 제조방법 및 그들을 함유한 약제학적 조성물
ATE130604T1 (de) Neue arylethylaminderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
KR950014073A (ko) 이소퀴놀린
IT1256345B (it) Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
ATE13286T1 (de) Pharmazeutisch aktive phenylcarbonsaeurederivate.
DE3854854D1 (de) 3-Desmethyl-mevalonsäurederivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen, ihre Verwendung sowie Zwischenprodukte
ATE161836T1 (de) 4-substituierte-2-deoxy-2,3-didehydro alpha-d- neuraminsäure antivirale derivate
DE59005254D1 (de) 24-Homo-Vitamin-D-Derivate, Verfahren zu ihrer Herstellung; diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung als Arzneimittel.
HUP9702042A2 (hu) 1,1,2-trifenil-but-1-én-származékok alkalmazása atherosclerosis kezelésére alkalmas gyógyszerkészítmények előállítására
HUP9802096A2 (hu) Piperidino-alkanol-vegyületeket tartalmazó orális adagolású oldat formájú gyógyszerkészítmény, és eljárás előállítására
TNSN87012A1 (fr) Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
ATE183188T1 (de) Cephalosporinderivative und verfahren zu ihrer herstellung
HUP9701660A2 (hu) 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények
ATE8401T1 (de) Anthracyclin-glycoside, verfahren zu ihrer herstellung, zwischenprodukte und ihre herstellung und arzneimittel.
EP0137442A3 (de) Cephalosporinderivate und Verfahren zu ihrer Herstellung
KR890001965A (ko) 스퍼구알린 관련 유도체
FR2395272A1 (fr) Nouveaux medicaments derives de l'acide amidinopenicillanique
CA2274133A1 (fr) Nouveaux derives tetrahydropyridiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BR9807406A (pt) Formulação farmacêutica, e, processo para a preparação das mesmas
FR2691149B1 (fr) Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
EP0334281A3 (de) Cephalosporinderivate und Verfahren zu ihrer Herstellung
NO974651L (no) Biologisk aktive ureidoderivater som er nyttige i behandlingen av multippel sklerose
KR920008035A (ko) 타이로신 유도체 및 그 제조방법

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: AVENTISUB II INC., US

Free format text: FORMER OWNER(S): AVENTIS HOLDINGS INC., US; AVENTIS PHARMACEUTICALS INC., US; HMR PHARMA, INC., US; HOECHST MARION ROUSSEL, INC., US

FH91 Appointment of a representative

Free format text: FORMER REPRESENTATIVE(S): SOMLAI MARIA, S.B.G. & K. SZABADALMI UEGYVIVOEI IRODA, HU

Representative=s name: DANUBIA SZABADALMI ES JOGI IRODA KFT., HU

FH92 Termination of representative

Representative=s name: SOMLAI MARIA, S.B.G. & K. SZABADALMI UEGYVIVOE, HU